Clinical outcomes, anticoagulation practice patterns, and quality of life after cancer-associated pulmonary embolism: secondary outcomes of the Hydra randomized clinical trial
Clinical outcomes, anticoagulation practice patterns, and quality of life after cancer-associated pulmonary embolism: secondary outcomes of the Hydra randomized clinical trial. // Research and Practice in Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2475037926036769?dgcid=rss_sd_all
Clinical outcomes, anticoagulation practice patterns, and quality of life after cancer-associated pulmonary embolism: secondary outcomes of the Hydra randomized clinical trial. Research and Practice in Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S2475037926036769?dgcid=rss_sd_all
“Clinical outcomes, anticoagulation practice patterns, and quality of life after cancer-associated pulmonary embolism: secondary outcomes of the Hydra randomized clinical trial.” Research and Practice in Thrombosis and Haemostasis.
@article{article64650,
title = {Clinical outcomes, anticoagulation practice patterns, and quality of life after cancer-associated pulmonary embolism: secondary outcomes of the Hydra randomized clinical trial},
journal = {Research and Practice in Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2475037926036769?dgcid=rss_sd_all}
}